BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Munich Startup - ECPv5.5.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Munich Startup
X-ORIGINAL-URL:https://www.munich-startup.de
X-WR-CALDESC:Veranstaltungen für Munich Startup
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260615T140000
DTEND;TZID=Europe/Berlin:20260615T150000
DTSTAMP:20260611T031040
CREATED:20260521T080836Z
LAST-MODIFIED:20260521T080836Z
UID:121020-1781532000-1781535600@www.munich-startup.de
SUMMARY:Online: Biotech Goes Global 2026 - United States
DESCRIPTION:Navigating U.S. Biotech Hubs\, Sector Strengths and IP Strategy \nThis web seminar is part of our international “Biotech Goes Global” series\, supporting Bavarian biotech companies in accessing key global markets. This edition places the spotlight on the United States – a highly dynamic life sciences environment characterised by world‑leading research hubs\, global pharmaceutical players\, a strong venture ecosystem\, and distinct collaboration cultures. \nJoin us to explore how Bavarian and European life sciences companies can strategically engage with U.S. biotech hubs\, identify relevant sector opportunities\, and understand critical success factors when entering or operating in the U.S. market. \nThis session addresses key considerations for companies in the health sector (including biotechnology\, pharmaceuticals\, medical technology\, and digital health) that are interested in gaining a better understanding of the U.S. life sciences landscape. \nThe webinar combines ecosystem insights with practical perspectives on sector focus and intellectual property\, and is particularly valuable for companies planning international expansion\, partnerships\, or participation in Bio International and other U.S. conferences. \nIn this session\, you will: \n\ngain an overview of leading U.S. biotech hubs and their distinctive innovation ecosystems\nlearn about flagship sectors and therapeutic strengths (such as oncology or regenerative medicine) and where current opportunities lie\nunderstand the role of accelerators and innovation programmes in facilitating market entry and collaboration\nreceive practical insights into IP strategy\, why it is critical when operating in the U.S. market\, and how it impacts long‑term venture success\n\nHier findet Ihr mehr Informationen zu der Veranstaltung.
URL:https://www.munich-startup.de/veranstaltung/online-biotech-goes-global-2026-united-states/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://www.munich-startup.de/wp-content/uploads/2018/12/Bio_M_webklein-2.jpg
END:VEVENT
END:VCALENDAR